4.22 USD
↘ 0.32 (7.05%)AT CLOSE (03:59 PM EDT)
Savara Inc.
SVRANASDAQ • USD
4.34
↗ 0.12 (2.84%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
4.34
↗ 0.12 (2.84%)
Market: CLOSED
Savara Inc. (SVRA) trades at $4.22 per share. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. SVRA is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Oct 23, 2026.
Open?$4.52
High?$4.58
Low?$4.13
Prev. Close?$4.54
Volume?2.8M
Avg. Volume?2.4M
VWAP?$4.22
Rel. Volume?1.17x
Bid / Ask
Bid?$4.25 × 700
Ask?$4.58 × 100
Spread?$0.33
Midpoint?$4.42
Valuation & Ratios
Market Cap?867.0M
Shares Out?205.5M
Float?143.3M
Float %?69.8%
P/E Ratio?N/A
P/B Ratio?6.04
EPS?-$0.68
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
Employees
70
Market Cap
867.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1996-11-18
Address
6836 BEE CAVE ROAD
AUSTIN, TX 78746
Phone: 51285113796
AUSTIN, TX 78746
Phone: 51285113796
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?94
Momentum?50
Short Sent.?30
Piotroski F-Score?0/9Weak
Altman Z-Score?4.27Safe
Confidence?48%Low
Short InterestSqueeze Risk
Short % of Float?30.39%Squeeze Risk
Short Interest?43.6M
Days to Cover?17.2
Free Float143.3M
Avg Daily Volume2.5M
Settlement Date2026-09-30
Financial Health
Current Ratio?10.13Strong
Quick Ratio?10.13Strong
Cash Ratio?2.38Strong
Debt/Equity?0.21Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?6.04FAIR▾
Peers100
S&P30
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-6.0CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-97.0%WEAK▾
S&P3
ROA?-72.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-110660000
Enterprise Value?$855.4M
Fundamentals ratios updated end of day